{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T13:49:03Z","timestamp":1791726543843,"version":"4.3.4"},"reference-count":79,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T00:00:00Z","timestamp":1667779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2018\/29\/N\/NZ2\/00802"],"award-info":[{"award-number":["2018\/29\/N\/NZ2\/00802"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2019\/35\/N\/NZ2\/00505"],"award-info":[{"award-number":["2019\/35\/N\/NZ2\/00505"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundacja Sanfilippo Poland","award":["21.01.2019"],"award-info":[{"award-number":["21.01.2019"]}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s13311-022-01323-7","type":"journal-article","created":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T17:06:44Z","timestamp":1667840804000},"page":"254-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Activities of (Poly)phenolic Antioxidants and Other Natural Autophagy Modulators in the Treatment of Sanfilippo Disease: Remarkable Efficacy of Resveratrol in Cellular and Animal Models"],"prefix":"10.1016","volume":"20","author":[{"given":"Estera","family":"Rintz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Podlacha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzanna","family":"Cyske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Pierzynowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"W\u0119grzyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0820-7204","authenticated-orcid":false,"given":"Lidia","family":"Gaffke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-022-01323-7_bib1","series-title":"Mucopolysaccharidoses Update","first-page":"211","article-title":"Mucopolysaccharidosis type III: clinical features, biochemistry, diagnosis, genetics, and treatment","author":"W\u0119grzyn","year":"2018"},{"key":"10.1007\/s13311-022-01323-7_bib2","series-title":"Mucopolysaccharidoses Update","first-page":"51","article-title":"Mucopolysaccharidosis type III (Sanfilippo disease) subtypes A, B, C, D: molecular mechanism and therapeutic effect","author":"Pierzynowska","year":"2018"},{"key":"10.1007\/s13311-022-01323-7_bib3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/jcm9020344","article-title":"Molecular bases of neurodegeneration and cognitive decline, the major burden of Sanfilippo disease","volume":"9","author":"Heon-Roberts","year":"2020","journal-title":"J Clin Med"},{"key":"10.1007\/s13311-022-01323-7_bib4","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.3390\/ijms21217819","article-title":"Sanfilippo syndrome: molecular basis, disease models and therapeutic approaches","volume":"21","author":"Benet\u00f3","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1007\/s13311-022-01323-7_bib5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/apa.12169","article-title":"Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit\/hyperactivity disorder or autism spectrum disorder","volume":"102","author":"Wijburg","year":"2013","journal-title":"Acta Paediatr"},{"key":"10.1007\/s13311-022-01323-7_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11011-017-0111-4","article-title":"How close are we to therapies for Sanfilippo disease?","volume":"33","author":"Gaffke","year":"2018","journal-title":"Metab Brain Dis"},{"key":"10.1007\/s13311-022-01323-7_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/jcpt.12136","article-title":"Current and potential therapeutic strategies for mucopolysaccharidoses","volume":"39","author":"Noh","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"10.1007\/s13311-022-01323-7_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.omtm.2018.05.002","article-title":"Targeting heparan sulfate proteoglycans as a novel therapeutic strategy for mucopolysaccharidoses","volume":"10","author":"De Pasquale","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1007\/s13311-022-01323-7_bib9","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10545-014-9718-3","article-title":"Treatment of lysosomal storage disorders: successes and challenges","volume":"37","author":"Hollak","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1007\/s13311-022-01323-7_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jimd.12316","article-title":"Novel therapies for mucopolysaccharidosis type III","volume":"44","author":"Yilmaz","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"10.1007\/s13311-022-01323-7_bib11","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3390\/ijms21041204","article-title":"Underestimated aspect of mucopolysaccharidosis pathogenesis: global changes in cellular processes revealed by transcriptomic studies","volume":"21","author":"Gaffke","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1007\/s13311-022-01323-7_bib12","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.3390\/ijms21093194","article-title":"Transcriptomic changes related to cellular processes with particular emphasis on cell activation in lysosomal storage diseases from the group of mucopolysaccharidoses","volume":"21","author":"Rintz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1007\/s13311-022-01323-7_bib13","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s11011-020-00614-2","article-title":"Changes in expressions of genes involved in the regulation of cellular processes in mucopolysaccharidoses as assessed by fibroblast culture-based transcriptomic analyses","volume":"35","author":"Gaffke","year":"2020","journal-title":"Metab Brain Dis"},{"key":"10.1007\/s13311-022-01323-7_bib14","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.3390\/ijms22052766","article-title":"Gene expression-related changes in morphologies of organelles and cellular component organization in mucopolysaccharidoses","volume":"22","author":"Gaffke","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1007\/s13311-022-01323-7_bib15","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1474-4422(17)30169-2","article-title":"Intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome: an uncontrolled phase 1\/2 clinical trial","volume":"16","author":"Tardieu","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1007\/s13311-022-01323-7_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ymgme.2018.10.006","article-title":"Intrathecal heparan-N-sulfatase in patients with Sanfilippo syndrome type A: a phase IIb randomized trial","volume":"126","author":"Wijburg","year":"2019","journal-title":"Mol Genet Metab"},{"key":"10.1007\/s13311-022-01323-7_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ymgme.2018.12.003","article-title":"Final results of the phase 1\/2, open-label clinical study of intravenous recombinant human N-acetyl-alpha-d-glucosaminidase (SBC-103) in children with mucopolysaccharidosis IIIB","volume":"126","author":"Whitley","year":"2019","journal-title":"Mol Genet Metab"},{"key":"10.1007\/s13311-022-01323-7_bib18","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/jimd.12407","article-title":"High dose genistein in Sanfilippo syndrome: a randomised controlled trial","volume":"44","author":"Ghosh","year":"2021","journal-title":"J Inherit Metab Dis"},{"key":"10.1007\/s13311-022-01323-7_bib19","article-title":"A cure for Sanfilippo syndrome? A summary of current therapeutic approaches and their promise","volume":";8","author":"Pearse","year":"2020","journal-title":"Med Res Arch"},{"key":"10.1007\/s13311-022-01323-7_bib20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.biopha.2018.05.007","article-title":"Autophagy in health and disease: a comprehensive review","volume":"104","author":"Saha","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1007\/s13311-022-01323-7_bib21","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/1440-1681.13500","article-title":"Targeting autophagy in neurodegenerative diseases: from molecular mechanisms to clinical therapeutics","volume":"48","author":"Ajoolabady","year":"2021","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1007\/s13311-022-01323-7_bib22","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/15548627.2018.1474313","article-title":"Trehalose reduces retinal degeneration, neuroinflammation and storage burden caused by a lysosomal hydrolase deficiency","volume":"14","author":"Lotfi","year":"2018","journal-title":"Autophagy"},{"key":"10.1007\/s13311-022-01323-7_bib23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12017-019-08559-1","article-title":"Mucopolysaccharidosis and autophagy: controversies on the contribution of the process to the pathogenesis and possible therapeutic applications","volume":"22","author":"Pierzynowska","year":"2020","journal-title":"Neuromolecular Med"},{"key":"10.1007\/s13311-022-01323-7_bib24","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1080\/15548627.2021.1961076","article-title":"Protein aggregation and autophagy dysfunction: new lessons from mucopolysaccharidoses","volume":"17","author":"Monaco","year":"2021","journal-title":"Autophagy"},{"key":"10.1007\/s13311-022-01323-7_bib25","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.3390\/ijms21124211","article-title":"Targeted metabolomic analysis of a mucopolysaccharidosis IIIB mouse model reveals an imbalance of branched-chain amino acid and fatty acid metabolism","volume":"21","author":"De Pasquale","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1007\/s13311-022-01323-7_bib26","doi-asserted-by":"crossref","first-page":"e0131662","DOI":"10.1371\/journal.pone.0131662","article-title":"The murine model of mucopolysaccharidosis IIIB develops cardiopathies over time leading to heart failure","volume":"10","author":"Schiattarella","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1007\/s13311-022-01323-7_bib27","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s11011-018-0214-6","article-title":"Autophagy stimulation as a promising approach in treatment of neurodegenerative diseases","volume":"33","author":"Pierzynowska","year":"2018","journal-title":"Metab Brain Dis"},{"key":"10.1007\/s13311-022-01323-7_bib28","doi-asserted-by":"crossref","first-page":"555409","DOI":"10.3389\/fcell.2020.555409","article-title":"Natural compounds and autophagy: allies against neurodegeneration","volume":"8","author":"Stacchiotti","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1007\/s13311-022-01323-7_bib29","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.3390\/ijms18071343","article-title":"Capsaicin induces autophagy and apoptosis in human nasopharyngeal carcinoma cells by downregulating the PI3K\/AKT\/mTOR pathway","volume":"18","author":"Lin","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1007\/s13311-022-01323-7_bib30","first-page":"4827","article-title":"Capsaicin induces apoptosis and autophagy in human melanoma cells","volume":"17","author":"Chu","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1007\/s13311-022-01323-7_bib31","doi-asserted-by":"crossref","first-page":"105297","DOI":"10.1016\/j.neuint.2022.105297","article-title":"Neuroprotective effects of curcumin via autophagy induction in 6-hydroxydopamine Parkinson's models","volume":"155","author":"He","year":"2022","journal-title":"Neurochem Int"},{"key":"10.1007\/s13311-022-01323-7_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3390\/antiox10010123","article-title":"Modulation of autophagy in cancer cells by dietary polyphenols","volume":"10","author":"Musial","year":"2021","journal-title":"Antioxidants"},{"key":"10.1007\/s13311-022-01323-7_bib33","first-page":"1337","article-title":"Curcumin promotes the survival of ischemic random skin flaps via autophagy","volume":"13","author":"Tu","year":"2021","journal-title":"Am J Transl Res"},{"key":"10.1007\/s13311-022-01323-7_bib34","first-page":"3440","article-title":"Resveratrol inhibits hypertrophic scars formation by activating autophagy via the miR-4654\/Rheb axis","volume":"22","author":"Pang","year":"2020","journal-title":"Mol Med Rep"},{"key":"10.1007\/s13311-022-01323-7_bib35","doi-asserted-by":"crossref","first-page":"e2000377","DOI":"10.1002\/mnfr.202000377","article-title":"Autophagy activation by resveratrol reduces severity of experimental rheumatoid arthritis","volume":"65","author":"Fern\u00e1ndez-Rodr\u00edguez","year":"2021","journal-title":"Mol Nutr Food Res"},{"key":"10.1007\/s13311-022-01323-7_bib36","doi-asserted-by":"crossref","first-page":"5296341","DOI":"10.1155\/2020\/5296341","article-title":"Autophagy upregulation by the TFEB inducer trehalose protects against oxidative damage and cell death associated with NRF2 inhibition in human RPE cells","volume":"2020","author":"Abokyi","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"10.1007\/s13311-022-01323-7_bib37","first-page":"1","article-title":"Trehalose causes low-grade lysosomal stress to activate TFEB and the autophagy-lysosome biogenesis response","volume":"11","author":"Jeong","year":"2021","journal-title":"Autophagy"},{"key":"10.1007\/s13311-022-01323-7_bib38","first-page":"3642","article-title":"Calcitriol promotes survival of experimental random pattern flap via activation of autophagy","volume":"9","author":"Chen","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1007\/s13311-022-01323-7_bib39","doi-asserted-by":"crossref","first-page":"108694","DOI":"10.1016\/j.abb.2020.108694","article-title":"Calcitriol alleviates ethanol-induced hepatotoxicity via AMPK\/mTOR-mediated autophagy","volume":"697","author":"Yuan","year":"2021","journal-title":"Arch Biochem Biophys"},{"key":"10.1007\/s13311-022-01323-7_bib40","doi-asserted-by":"crossref","first-page":"173534","DOI":"10.1016\/j.ejphar.2020.173534","article-title":"Has resveratrol a potential for mucopolysaccharidosis treatment?","volume":"888","author":"Rintz","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1007\/s13311-022-01323-7_bib41","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.neuropharm.2019.01.030","article-title":"Autophagy-dependent mechanism of genistein-mediated elimination of behavioral and biochemical defects in the rat model of sporadic Alzheimer's disease","volume":"148","author":"Pierzynowska","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1007\/s13311-022-01323-7_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15548627.2020.1797280","article-title":"Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)","volume":"17","author":"Klionsky","year":"2021","journal-title":"Autophagy"},{"key":"10.1007\/s13311-022-01323-7_bib43","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/sj.ejhg.5201623","article-title":"Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses","volume":"14","author":"Piotrowska","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"10.1007\/s13311-022-01323-7_bib44","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1423-0127-16-26","article-title":"Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway","volume":"16","author":"Jak\u00f3bkiewicz-Banecka","year":"2009","journal-title":"J Biomed Sci"},{"key":"10.1007\/s13311-022-01323-7_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10545-009-9029-2","article-title":"Storage correction in cells of patients suffering from mucopolysaccharidoses types IIIA and VII after treatment with genistein and other isoflavones","volume":"33","author":"Arfi","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1007\/s13311-022-01323-7_bib46","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1476-5381.2009.00565.x","article-title":"Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II","volume":"159","author":"Friso","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1007\/s13311-022-01323-7_bib47","doi-asserted-by":"crossref","first-page":"17054","DOI":"10.1074\/jbc.M114.555300","article-title":"The phytoestrogen genistein modulates lysosomal metabolism and transcription factor EB (TFEB) activation","volume":"289","author":"Moskot","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-022-01323-7_bib48","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1074\/jbc.M110.192062","article-title":"Secondary storage of dermatan sulfate in Sanfilippo disease","volume":"286","author":"Lamanna","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-022-01323-7_bib49","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jpeds.2011.04.040","article-title":"Evaluation of miglustat treatment in patients with type III mucopolysaccharidosis: a randomized, double-blind, placebo-controlled study","volume":"159","author":"Guffon","year":"2011","journal-title":"J Pediatr"},{"key":"10.1007\/s13311-022-01323-7_bib50","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s10545-014-9703-x","article-title":"Genistein increases glycosaminoglycan levels in mucopolysaccharidosis type I cell models","volume":"37","author":"Kingma","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1007\/s13311-022-01323-7_bib51","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1159\/000490985","article-title":"Genistein enhances or reduces glycosaminoglycan quantity in a cell type-specific manner","volume":"47","author":"Lan","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"10.1007\/s13311-022-01323-7_bib52","doi-asserted-by":"crossref","first-page":"e14192","DOI":"10.1371\/journal.pone.0014192","article-title":"Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease","volume":"5","author":"Malinowska","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1007\/s13311-022-01323-7_bib53","first-page":"77","article-title":"Adverse effects of genistein in a mucopolysaccharidosis type I mouse model","volume":"23","author":"Kingma","year":"2015","journal-title":"N. JIMD Rep"},{"key":"10.1007\/s13311-022-01323-7_bib54","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.curtheres.2008.04.002","article-title":"Genistin-rich soy isoflavone extract in substrate re-duction therapy for Sanfilippo syndrome: an open-label, pilot study in 10 pediatric patients","volume":"69","author":"Piotrowska","year":"2008","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1007\/s13311-022-01323-7_bib55","doi-asserted-by":"crossref","first-page":"CR196","DOI":"10.12659\/MSM.881715","article-title":"Two-year follow-up of Sanfilippo disease patients treated with a genistein-rich isoflavone extract: assessment of effects on cognitive functions and general status of patients","volume":"17","author":"Piotrowska","year":"2011","journal-title":"Med Sci Monit"},{"key":"10.1007\/s13311-022-01323-7_bib56","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/ajmg.a.34146","article-title":"Im-provement in the range of joint motion in seven patients with mucopolysaccharidosis type II during experimental gene expression-targeted isoflavone therapy (GET IT)","volume":"155A","author":"Marucha","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1007\/s13311-022-01323-7_bib57","first-page":"21","article-title":"The use of elevated doses of genistein-rich soy extract in the gene expres-sion-targeted isoflavone therapy for Sanfilippo disease patients","volume":"5","author":"Malinov\u00e1","year":"2012","journal-title":"JIMD Rep"},{"key":"10.1007\/s13311-022-01323-7_bib58","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s10545-011-9342-4","article-title":"Genistein supplementation in patients affected by Sanfilippo disease","volume":"34","author":"Delgadillo","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1007\/s13311-022-01323-7_bib59","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.22643","article-title":"Genistein in Sanfilippo disease: a randomized controlled crossover trial","volume":"71","author":"de Ruijter","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-022-01323-7_bib60","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ymgme.2013.06.012","article-title":"High dose genistein aglycone therapy is safe in patients with mucopoly-saccharidoses involving the central nervous system","volume":"109","author":"Kim","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1007\/s13311-022-01323-7_bib61","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/hmg\/ddq555","article-title":"Disruption of adaptive energy metabolism and elevated ribosomal p-S6K1 levels contribute to INCL pathogenesis: partial rescue by resveratrol","volume":"20","author":"Wei","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-022-01323-7_bib62","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbrc.2011.09.019","article-title":"Protective potential of resveratrol against oxidative stress and apoptosis in Batten disease lymphoblast cells","volume":"414","author":"Yoon","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1007\/s13311-022-01323-7_bib63","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1093\/hmg\/dds038","article-title":"The blood-brain barrier is disrupted in a mouse model of infantile neuronal ceroid lipofuscinosis: amelioration by resveratrol","volume":"21","author":"Saha","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1007\/s13311-022-01323-7_bib64","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/nar\/gkt987","article-title":"Functional characterization of the common c.-32\u201313T>G mutation of GAA gene: identification of potential therapeutic agents","volume":"42","author":"Dardis","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1007\/s13311-022-01323-7_bib65","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1248\/bpb.b14-00712","article-title":"Anti-apoptotic and beneficial metabolic activities of resveratrol in type II Gaucher disease","volume":"38","author":"Yoo","year":"2015","journal-title":"Biol Pharm Bull"},{"key":"10.1007\/s13311-022-01323-7_bib66","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/ptr.5304","article-title":"Therapeutic potential of resveratrol in type I Gaucher disease","volume":"29","author":"Seo","year":"2015","journal-title":"Phytother Res"},{"key":"10.1007\/s13311-022-01323-7_bib67","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1080\/15384101.2017.1380134","article-title":"Death by over-eating: the Gaucher disease associated gene GBA1, identified in a screen for mediators of autophagic cell death, is necessary for devel-opmental cell death in Drosophila midgut","volume":"16","author":"Dasari","year":"2017","journal-title":"Cell Cycle"},{"key":"10.1007\/s13311-022-01323-7_bib68","doi-asserted-by":"crossref","first-page":"dmm036954","DOI":"10.1242\/dmm.036954","article-title":"Neuromuscular degeneration and locomotor deficit in a Drosophila model of mucopolysaccharidosis VII is attenuated by treatment with resveratrol","volume":"11","author":"Bar","year":"2018","journal-title":"Dis Model Mech"},{"key":"10.1007\/s13311-022-01323-7_bib69","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.nbd.2019.05.011","article-title":"Dysregulated autophagy as a new aspect of the molecular pathogenesis of Krabbe disease","volume":"129","author":"Del Grosso","year":"2019","journal-title":"Neurobiol Dis"},{"key":"10.1007\/s13311-022-01323-7_bib70","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1042\/BCJ20200676","article-title":"Resveratrol promotes lysosomal function via ER calcium-dependent TFEB activation to ameliorate lipid accumulation","volume":"478","author":"Shao","year":"2021","journal-title":"Biochem J"},{"key":"10.1007\/s13311-022-01323-7_bib71","doi-asserted-by":"crossref","first-page":"e772","DOI":"10.1371\/journal.pone.0000772","article-title":"Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type B","volume":"2","author":"Heldermon","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1007\/s13311-022-01323-7_bib72","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1038\/s41467-021-23903-5","article-title":"Altered heparan sulfate metabolism during development triggers dopamine-dependent autistic-behaviours in models of lysosomal storage disorders","volume":"12","author":"De Risi","year":"2021","journal-title":"Nat Commun"},{"key":"10.1007\/s13311-022-01323-7_bib73","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s13353-022-00703-1","article-title":"Misdiagnosis in mucopolysaccharidoses","volume":"63","author":"Wi\u015bniewska","year":"2022","journal-title":"J Appl Genet"},{"key":"10.1007\/s13311-022-01323-7_bib74","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.2147\/JMDH.S362994","article-title":"Sanfilippo syndrome: optimizing care with a multidisciplinary approach","volume":"15","author":"Cyske","year":"2022","journal-title":"J Multidiscip Healthc"},{"key":"10.1007\/s13311-022-01323-7_bib75","doi-asserted-by":"crossref","first-page":"593","DOI":"10.3390\/genes13040593","article-title":"Complex changes in the efficiency of the expression of many genes in monogenic diseases, mucopolysaccharidoses, may arise from significant disturbances in the levels of factors involved in the gene expression regulation processes","volume":"13","author":"Cyske","year":"2022","journal-title":"Genes"},{"key":"10.1007\/s13311-022-01323-7_bib76","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0006-8993(02)03543-6","article-title":"Resveratrol protects against global cerebral ischemic injury in gerbils","volume":"958","author":"Wang","year":"2002","journal-title":"Brain Res"},{"key":"10.1007\/s13311-022-01323-7_bib77","doi-asserted-by":"crossref","first-page":"11676","DOI":"10.1021\/acs.jafc.1c02898","article-title":"Evaluation of blood-brain barrier permeability of polyphenols, anthocyanins, and their metabolites","volume":"69","author":"Shimazu","year":"2021","journal-title":"J Agric Food Chem"},{"key":"10.1007\/s13311-022-01323-7_bib78","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3389\/fphar.2018.01261","article-title":"Resveratrol brain delivery for neurological disorders prevention and treatment","volume":"9","author":"Andrade","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1007\/s13311-022-01323-7_bib79","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/10837450.2019.1680690","article-title":"Pharmacokinetics and brain targeting of trans-resveratrol loaded mixed micelles in rats following intravenous administration","volume":"25","author":"Katekar","year":"2020","journal-title":"Pharm Dev Technol"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01323-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-022-01323-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923001204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-022-01323-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T06:37:33Z","timestamp":1761806253000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923001204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1878747923001204"],"URL":"https:\/\/doi.org\/10.1007\/s13311-022-01323-7","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activities of (Poly)phenolic Antioxidants and Other Natural Autophagy Modulators in the Treatment of Sanfilippo Disease: Remarkable Efficacy of Resveratrol in Cellular and Animal Models","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-022-01323-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 The Author(s). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}